0001104659-24-008883.txt : 20240131
0001104659-24-008883.hdr.sgml : 20240131
20240131171635
ACCESSION NUMBER: 0001104659-24-008883
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240129
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weisman Howard J.
CENTRAL INDEX KEY: 0001811802
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41475
FILM NUMBER: 24583947
MAIL ADDRESS:
STREET 1: C/O PAXMEDICA, INC.
STREET 2: 900 E. HAMILTON AVENUE, SUITE 100
CITY: CAMPBELL
STATE: CA
ZIP: 95008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PaxMedica, Inc.
CENTRAL INDEX KEY: 0001811623
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 303 SOUTH BROADWAY, SUITE 125
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 914-987-2876
MAIL ADDRESS:
STREET 1: 303 SOUTH BROADWAY, SUITE 125
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
tm244774-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-29
0
0001811623
PaxMedica, Inc.
PXMD
0001811802
Weisman Howard J.
C/O PAXMEDICA, INC.
303 SOUTH BROADWAY, SUITE 125
TARRYTOWN
NY
10591
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-01-29
4
S
0
372
0.47
D
37675
D
The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan to, inter alia, pay tax withholding on vested RSUs.
The sale price represents the weighted average sale price of the shares sold ranging from $0.47 to $0.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
/s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
2024-01-31